Literature DB >> 18157608

[Steatohepatitis and cirrhosis: first manifestation 23 years after jejunoileal bypass surgery].

Peter Piringer1, Robert Buder, Fritz Firlinger, Christine Kapral, Christian Luft, Wolfgang Sega, Friedrich Wewalka, Kurt Lenz.   

Abstract

Intestinal shunting procedures followed by gastrointestinal bypass surgery have been used as therapeutic modalities in the treatment of morbid obesity since the mid 1950s. Enthusiasm reached its peak in the early 1960s with the introduction of the jejunoileal bypass, however began to wane as various complications were identified in the remote postoperative period and later. Finally, the jejunoileal bypass was abandoned in the 1980s. Apart from renal disorders, it frequently resulted in abnormal liver function and liver failure which are attributed to fatty infiltration. We report a 56-year-old woman, who underwent jejunoileal bypass surgery 23 years ago. She was admitted to our ICU because of hepatic encephalopathy IV, caused by upper gastrointestinal bleeding. Beside hepatic encephalopathy there were signs of severe liver failure (INR 2.8, cholesterol 32 mg/dl, ICG PDR 5%). Liver biopsy showed fatty infiltration and cirrhosis. Excluding other causes of liver disease, severe fatty liver disease following jejunoileal bypass surgery was diagnosed. The very late onset of severe liver disease emphasizes the importance of lifelong follow-up of these patients.

Entities:  

Mesh:

Year:  2007        PMID: 18157608     DOI: 10.1007/s00508-007-0850-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  37 in total

1.  Overweight and obesity worldwide now estimated to involve 1.7 billion people.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

2.  Negative trials in nonalcoholic steatohepatitis: why they happen and what they teach us.

Authors:  Jeanne M Clark; Frederick L Brancati
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

3.  Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.

Authors:  Keith D Lindor; Kris V Kowdley; E Jenny Heathcote; M Edwyn Harrison; Roberta Jorgensen; Paul Angulo; James F Lymp; Lawrence Burgart; Patrick Colin
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

4.  Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

Authors:  Samuel Klein; Bettina Mittendorfer; J Christopher Eagon; Bruce Patterson; Lafaine Grant; Nikki Feirt; Ekihiro Seki; David Brenner; Kevin Korenblat; Jennifer McCrea
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

5.  Bariatric surgery worldwide 2003.

Authors:  Henry Buchwald; Stanley E Williams
Journal:  Obes Surg       Date:  2004-10       Impact factor: 4.129

6.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

7.  Long-term consequences after jejunoileal bypass for morbid obesity.

Authors:  M P Hocking; G L Davis; D A Franzini; E R Woodward
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

8.  Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon.

Authors:  C Kapral; F Wewalka; V Praxmarer; K Lenz; A F Hofmann
Journal:  Z Gastroenterol       Date:  2004-07       Impact factor: 2.000

9.  Jejunoileal bypass. Long-term results.

Authors:  C H Organ; M M Cegielski; B J Grabner; H E Keig; J A Saporta
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

10.  Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more
  2 in total

1.  Liver failure in an obese middle-aged woman after biliointestinal bypass.

Authors:  Dolores Sgambato; Gaetano Cotticelli; Ilario de Sio; Annalisa Funaro; Anna Del Prete; Chiara de Sio; Lorenzo Romano; Alessandro Federico; Antonietta Gravina; Agnese Miranda; Carmelina Loguercio; Marco Romano
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

Review 2.  Benchmarking best practices in weight loss surgery.

Authors:  Robert B Lim; George L Blackburn; Daniel B Jones
Journal:  Curr Probl Surg       Date:  2010-02       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.